Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR)

95 filings reported holding BNR - Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share as of Q4 2021.
Burning Rock Biotech Ltd - American Depository Shares ("ADSs") of the Issuer, each ADS representing one Class A Ordinary Share, par value $0.0002 per share (BNR) has 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 25,495,461 shares .
Largest 10 shareholders include BAILLIE GIFFORD & CO (8,900,503 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (2,211,094 shares), MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC (1,566,908 shares), ORBIMED ADVISORS LLC (1,452,402 shares), BlackRock Inc. (1,296,216 shares), CANADA PENSION PLAN INVESTMENT BOARD (1,238,000 shares), Sumitomo Mitsui Trust Holdings, Inc. (1,172,542 shares), VANGUARD GROUP INC (1,027,079 shares), ARK Investment Management LLC (847,539 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (593,222 shares).
This table shows the top 57 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.